Next activities...  
 
 
There is no activities for the moment.
 
 
 
 
 
Objective Measures of ADHD Symptoms Using the Quotient(TM) ADHD System May Reduce Cost of ADHD Drug Trials
 

Wednesday, October 28th 2009

(Reuters) – (...) Placebo response is a well-known phenomenon in ADHD clinical trials, where subjects report benefit when taking an inactive sugar pill. To achieve registration with the US FDA, drug developers must demonstrate that their product is statistically superior to placebo.  Placebo response increases the cost of clinical trials by requiring more subjects or longer observation to accomplish this crucial goal. This pilot study examined the concordance of the Quotient(TM) ADHD Test, an objective assessment tool to measure hyperactivity, inattention and impulsivity, with the current standard of care, clinical ADHD rating scales (ADHD-RS). Rating scales are questionnaires that ask the subject and/or parent about the severity and frequency of ADHD symptoms.

To read more...

 

http://www.reuters.com/article/pressRelease/idUS213760+21-Oct-2009+PRN20091021
 
 
Show more news
 
 
 
 

COPYRIGHT 2006 - 2019 | PANDA BLSO CA.